NCT00481871 2020-01-07Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative MalignanciesAcrotech Biopharma Inc.Phase 1/2 Completed119 enrolled 13 charts
NCT00511238 2017-08-31Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple MyelomaAmgenPhase 2 Completed312 enrolled 16 charts